PT4103158T - Composição que compreende ramipril e indapamida - Google Patents

Composição que compreende ramipril e indapamida

Info

Publication number
PT4103158T
PT4103158T PT217054584T PT21705458T PT4103158T PT 4103158 T PT4103158 T PT 4103158T PT 217054584 T PT217054584 T PT 217054584T PT 21705458 T PT21705458 T PT 21705458T PT 4103158 T PT4103158 T PT 4103158T
Authority
PT
Portugal
Prior art keywords
indapamide
ramipril
composition
Prior art date
Application number
PT217054584T
Other languages
English (en)
Original Assignee
Adamed Pharma S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamed Pharma S A filed Critical Adamed Pharma S A
Publication of PT4103158T publication Critical patent/PT4103158T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT217054584T 2020-02-10 2021-02-10 Composição que compreende ramipril e indapamida PT4103158T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20156309 2020-02-10

Publications (1)

Publication Number Publication Date
PT4103158T true PT4103158T (pt) 2024-11-07

Family

ID=74625960

Family Applications (1)

Application Number Title Priority Date Filing Date
PT217054584T PT4103158T (pt) 2020-02-10 2021-02-10 Composição que compreende ramipril e indapamida

Country Status (7)

Country Link
EP (2) EP4103158B1 (pt)
ES (1) ES2992213T3 (pt)
HR (1) HRP20241424T1 (pt)
PL (1) PL4103158T3 (pt)
PT (1) PT4103158T (pt)
RS (1) RS66060B1 (pt)
WO (2) WO2021162562A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4389118A1 (en) * 2022-12-22 2024-06-26 Zaklady Farmaceutyczne Polpharma S.A. Dry powder blend pharmaceutical composition comprising ramipril and indapamide
GR1010675B (el) * 2023-02-17 2024-04-23 Ιουλια Κλεωνος Τσετη Τριπλος συνδυασμος αντι-υπερτασικων φαρμακων αναστολεα μεα, ανταγωνιστη ασβεστιου και διουρητικης ενωσης για ταυτοχρονη απο του στοματος χορηγηση
EP4710920A1 (en) 2024-09-16 2026-03-18 Adamed Pharma S.A. Pharmaceutical composition comprising combination of amlodipine, ramipril and rosuvastatin
PL451300A1 (pl) * 2025-02-25 2025-09-01 Uniwersytet Medyczny Im. Karola Marcinkowskiego W Poznaniu Stabilna forma amorficzna bisoprololu fumaranu i bisoprololu fumaranu z ramiprilem oraz sposób ich otrzymywania

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US433A (en) 1837-10-20 Spring foe
US5151A (en) 1847-06-12 Improvement in compositions for currying leather
DE3739690A1 (de) 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE102004005009A1 (de) * 2004-01-30 2005-09-01 Krka Tovarna Zdravil, D.D. Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
KR20070085754A (ko) * 2004-11-05 2007-08-27 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정화된 라미프릴 조성물 및 제조 방법
WO2008124611A1 (en) 2007-04-05 2008-10-16 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions comprising ramipril and indapamide
US20100062062A1 (en) * 2008-09-11 2010-03-11 Aethos Pharmaceuticals, Inc. Stabilized Coating for Pharmaceutical Formulations
CA2754134C (en) * 2009-02-11 2018-09-18 Cadila Pharmaceuticals Ltd. Stable pharmaceutical composition for atherosclerosis
PL227900B1 (pl) * 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
HUP1300496A2 (hu) * 2013-08-16 2015-03-02 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Stabil kombinációs gyógyszerkészítmény
WO2020109319A1 (en) 2018-11-27 2020-06-04 Zaklady Farmaceutyczne Polpharma S.A Pharmaceutical composition comprising ramipril and indapamide

Also Published As

Publication number Publication date
EP4103158A1 (en) 2022-12-21
WO2021162562A3 (en) 2021-12-02
RS66060B1 (sr) 2024-11-29
ES2992213T3 (es) 2024-12-10
HRP20241424T1 (hr) 2024-12-20
EP4106733A2 (en) 2022-12-28
PL4103158T3 (pl) 2024-12-02
EP4103158B1 (en) 2024-09-04
WO2021162562A2 (en) 2021-08-19
WO2021160700A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
PL4103158T3 (pl) Kompozycja zawierająca ramipryl oraz indapamid
PL4208045T3 (pl) Kompozycje i sposoby
GB202011871D0 (en) Composition and method
GB202111040D0 (en) Compositions and methods
GB202108585D0 (en) Methods and compositions
GB202004677D0 (en) Methods and compositions
GB202111039D0 (en) Materials and methods
GB202013271D0 (en) Composition and method
GB202010449D0 (en) Method and composition
GB201911437D0 (en) Pressured adhesive composition and method
IL304824A (en) Phosphorofol methods and preparations
GB202116554D0 (en) Methods and compositions
GB202101160D0 (en) Materials and methods
GB202110091D0 (en) Methods and compositions
GB2600489B (en) Saw and methods
GB202212268D0 (en) Materials and methods
GB2603152B (en) Improved materials and methods
GB202202963D0 (en) Materials and methods
GB202408093D0 (en) Compositions and methods
GB202214719D0 (en) Compositions and methods
IL310092A (en) Preparations and methods
GB202308562D0 (en) Novel methods and uses
GB202106861D0 (en) Composition and uses
GB202001300D0 (en) Materials and methods
GB202110572D0 (en) Compositions and methods